Eli Lilly is dropping CVS Health's drug benefit plan for its employees after the healthcare conglomerate stopped covering the company's weight-loss drug in favor of Novo Nordisk's rival medication, ...

That said, the pharmacy giant still has a lot to do as it tries to fix parts of its business that still aren't performing as ...

CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter. The health care giant also hiked its 2025 forecast ...

FILE - CVS pharmacy and drive-thru signs are seen outside of CVS store in Park Ridge, Ill., Monday, April 29, 2024. CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits ...

Fintel reports that on October 24, 2025, UBS maintained coverage of CVS Health (NYSE:CVS) with a Buy recommendation. Analyst Price Forecast Suggests 1.99% Upside As of September 30, 2025, the average ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Investors are awaiting updates ...

Some customers might not be able to fill or pick up their prescriptions at CVS locations on Tuesday because of technical issues.A CVS spokesperson said in a statement Tuesday that the company is ...

(NEXSTAR) — While a system outage that impacted numerous CVS pharmacies has been resolved, according to a company spokesperson, it may still take you longer than expected to pick up your prescription ...